methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid

C24H28N6O4 — CID 118036020

IUPACmethyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid
SMILESCN(C(=O)O)c1ccc(-c2nc(N3CC4CCC(C3)O4)nc3c2cnn3C2CCOCC2)cc1
InChIInChI=1S/C24H28N6O4/c1-28(24(31)32)16-4-2-15(3-5-16)21-20-12-25-30(17-8-10-33-11-9-17)22(20)27-23(26-21)29-13-18-6-7-19(14-29)34-18/h2-5,12,17-19H,6-11,13-14H2,1H3,(H,31,32)
InChIKeyGAKGJCAKGDAMOG-UHFFFAOYSA-N
MW464.53 g/mol
LogP3.33
Rot. Bonds4

About methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid

methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid (PubChem CID 118036020) has the molecular formula C24H28N6O4 and a molecular weight of 464.53 g/mol. Its IUPAC name is methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid.

Molecular Properties

Compound Namemethyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid
PubChem CID118036020
Molecular FormulaC24H28N6O4
Molecular Weight464.53 g/mol
Exact Mass464.22
IUPAC Namemethyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid
SMILESCN(C(=O)O)c1ccc(-c2nc(N3CC4CCC(C3)O4)nc3c2cnn3C2CCOCC2)cc1
InChIInChI=1S/C24H28N6O4/c1-28(24(31)32)16-4-2-15(3-5-16)21-20-12-25-30(17-8-10-33-11-9-17)22(20)27-23(26-21)29-13-18-6-7-19(14-29)34-18/h2-5,12,17-19H,6-11,13-14H2,1H3,(H,31,32)
InChIKeyGAKGJCAKGDAMOG-UHFFFAOYSA-N
XLogP3.33
TPSA105.84 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500464.53
LogP ≤ 53.33
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid?
The IUPAC name of methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid (CID 118036020) is methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid.
What is the SMILES notation for methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid?
The canonical SMILES for methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid is CN(C(=O)O)c1ccc(-c2nc(N3CC4CCC(C3)O4)nc3c2cnn3C2CCOCC2)cc1.
What is the InChIKey of methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid?
The InChIKey is GAKGJCAKGDAMOG-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H28N6O4/c1-28(24(31)32)16-4-2-15(3-5-16)21-20-12-25-30(17-8-10-33-11-9-17)22(20)27-23(26-21)29-13-18-6-7-19(14-29)34-18/h2-5,12,17-19H,6-11,13-14H2,1H3,(H,31,32).
What are the key properties of methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid?
methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid has a molecular weight of 464.53 g/mol, XLogP of 3.33, 4 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for methyl-[4-[6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-yl]phenyl]carbamic acid is sourced from PubChem (CID 118036020), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).